38.09
+1.49(+4.07%)
Currency In USD
| Previous Close | 36.6 |
| Open | 36.8 |
| Day High | 39.24 |
| Day Low | 35.28 |
| 52-Week High | 39.29 |
| 52-Week Low | 11.26 |
| Volume | 2.04M |
| Average Volume | 2M |
| Market Cap | 3.25B |
| PE | -26.09 |
| EPS | -1.46 |
| Moving Average 50 Days | 31.36 |
| Moving Average 200 Days | 22.01 |
| Change | 1.49 |
If you invested $1000 in Liquidia Corporation (LQDA) since IPO date, it would be worth $3,431.53 as of January 14, 2026 at a share price of $38.09. Whereas If you bought $1000 worth of Liquidia Corporation (LQDA) shares 5 years ago, it would be worth $12,696.67 as of January 14, 2026 at a share price of $38.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
GlobeNewswire Inc.
Jan 09, 2026 11:30 AM GMT
Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in June 2025Generated more than $30 million of positive
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 07, 2026 12:00 PM GMT
MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences
GlobeNewswire Inc.
Nov 03, 2025 1:00 PM GMT
MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that members of the company’